DNTH
Common StockDianthus Therapeutics, Inc. /DE/
Reported Shares
1.9M
Position Mix
No options reported
Reported Value
$167.3M
Portfolio Weight
34.26%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$488.2M
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
DNTH
Common StockDianthus Therapeutics, Inc. /DE/
Reported Shares
1.9M
Position Mix
No options reported
Reported Value
$167.3M
Portfolio Weight
34.26%
CGON
Common StockCG Oncology, Inc.
Reported Shares
1.3M
Position Mix
Reported Value
$155.9M
Portfolio Weight
31.93%
ORKA
Common StockOruka Therapeutics, Inc.
Reported Shares
785.4K
Position Mix
No options reported
Reported Value
$65.4M
Portfolio Weight
13.40%
JBIO
Common StockJade Biosciences, Inc.
Reported Shares
2M
Position Mix
No options reported
Reported Value
$28.1M
Portfolio Weight
5.76%
ELVN
Common StockEnliven Therapeutics, Inc.
Reported Shares
550K
Position Mix
No options reported
Reported Value
$25.2M
Portfolio Weight
5.16%
CATX
Common StockPerspective Therapeutics, Inc.
Reported Shares
6.1M
Position Mix
No options reported
Reported Value
$16.7M
Portfolio Weight
3.42%
AKTS
Common StockAktis Oncology, Inc.
Reported Shares
484.2K
Position Mix
No options reported
Reported Value
$9.4M
Portfolio Weight
1.93%
IMUX
Common StockIMMUNIC, INC.
Reported Shares
669.9K
Position Mix
No options reported
Reported Value
$6.2M
Portfolio Weight
1.28%
MOBI
Common StockMobia Medical, Inc.
Reported Shares
324.7K
Position Mix
No options reported
Reported Value
$3.1M
Portfolio Weight
0.63%
PVLA
Common StockPALVELLA THERAPEUTICS, INC.
Reported Shares
20K
Position Mix
No options reported
Reported Value
$2.8M
Portfolio Weight
0.57%
NVCT
Common StockNuvectis Pharma, Inc.
Reported Shares
100.4K
Position Mix
No options reported
Reported Value
$2.1M
Portfolio Weight
0.43%
MSLE
Common StockSatellos Bioscience Inc.
Reported Shares
164K
Position Mix
No options reported
Reported Value
$1.4M
Portfolio Weight
0.29%
CNTX
Common StockContext Therapeutics Inc.
Reported Shares
4.1M
Position Mix
No options reported
Reported Value
$1.2M
Portfolio Weight
0.25%
KPTI
Common StockKaryopharm Therapeutics Inc.
Reported Shares
884.9K
Position Mix
No options reported
Reported Value
$1.1M
Portfolio Weight
0.22%
SENS
Common StockSenseonics Holdings, Inc.
Reported Shares
100K
Position Mix
No options reported
Reported Value
$1.0M
Portfolio Weight
0.21%
SCYX
Common StockSCYNEXIS INC
Reported Shares
153.6K
Position Mix
No options reported
Reported Value
$758.8K
Portfolio Weight
0.16%
AVLN
Common StockAvalyn Pharma Inc.
Reported Shares
20K
Position Mix
No options reported
Reported Value
$569.8K
Portfolio Weight
0.12%